Benzinga - Gainers
- Minim, Inc. (NASDAQ: MINM) shares rose 66.5% to $0.2903 in pre-market trading after gaining over 10% on Thursday. Minim, last month, reported worse-than-expected results.
- Lanvin Group (NASDAQ: LANV) shares rose 59.9% to $12.20 in pre-market trading after dropping over 22% on Thursday.
- Crown ElectroKinetics Corp. (NASDAQ: CRKN) rose 43.8% to $0.2640 in pre-market trading after jumping around 20% on Thursday.
- EUDA Health Holdings Limited (NASDAQ: EUDA) rose 25.5% to $2.07 in pre-market trading after gaining around 18% on Thursday.
- Exact Sciences Corporation (NASDAQ: EXAS) shares rose 16.8% to $52.11 in pre-market trading after competitor Guardant Health reported results from a study of its colorectal cancer detection blood test.
- IMAC Holdings, Inc. (NASDAQ: BACK) rose 15.8% to $0.2835 in pre-market trading after declining 7% on Thursday.
- Bit Brother Limited (NASDAQ: BTB) rose 15% to $7.28 in pre-market trading after gaining 24% on Thursday. Bit Brother recently announced a 1-for-15 reverse share split.
- Golden Sun Education Group Limited (NASDAQ: GSUN) rose 14.3% to $1.28 in pre-market trading after dropping around 10% on Thursday.
- China Pharma Holdings, Inc. (NYSE: CPHI) rose 11.4% to $0.1192 in pre-market trading after declining 10% on Thursday. China Pharma recently announced the acquisition of Dry Eye Disease Therapeutic Device Project.
- Remark Holdings, Inc. (NASDAQ: MARK) rose 10.7% to $0.19 in pre-market trading after declining 5% on Thursday.
- Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) shares rose 10.2% to $0.6634 in pre-market trading.
- Edgio, Inc. (NASDAQ: EGIO) rose 9.8% to $1.35 in pre-market trading. Edgio, last month, reported worse-than-expected Q3 sales results and issued Q4 sales guidance below analyst estimates.
- TD Holdings, Inc. (NASDAQ: GLG) rose 8.7% to $1.12 in pre-market trading after dropping over 13% on Thursday.
- Biora Therapeutics, Inc. (NASDAQ: BIOR) rose 8.6% to $0.19 in pre-market trading.
- DouYu International Holdings Limited (NASDAQ: DOYU) rose 6.8% to $1.26 in pre-market trading after dipping 10% on Thursday.
- Adobe (NASDAQ:ADBE) Inc. (NASDAQ: ADBE) rose 4.2% to $342.50 in pre-market trading after the company reported better-than-expected earnings for its fourth quarter. Adobe said it sees full-year revenue in a range of $19.1 billion to $19.3 billion versus estimates of $19.37 billion. The company expects full-year adjusted earnings to be between $15.15 and $15.45 per share versus estimates of $15.25 per share.
Losers
- Guardant Health, Inc. (NASDAQ: GH) fell 33.1% to $27.59 in pre-market trading after the company announced results from its ECLIPSE study evaluating the performance of its blood test for detecting colorectal cancer.
- Agrify Corporation (NASDAQ: AGFY) shares fell 22.8% to $0.6299 in pre-market trading after the company reported the launch of public offering.
- Avaya Holdings Corp. (NYSE: AVYA) shares fell 22.3% to $0.3996 in pre-market trading. The Wall Street Journal reported that Avaya is nearing Chapter 11 filing.
- Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) fell 22.1% to $0.3741 in pre-market trading. Faraday Future announced plans to start production of FF 91 Futurist in March 2023 and outlined financing progress and completion of product upgrades.
- MorphoSys AG (NASDAQ: MOR) shares fell 19.8% to $3.20 in pre-market trading. MorphoSys subsidiary Constellation Pharmaceuticals recently entered into a global licensing agreement with Novartis to research, develop and commercialize its pre-clinical inhibitors of a novel cancer target.
- Camber Energy, Inc. (NYSE: CEI) fell 15.5% to $0.0662 in pre-market trading. Camber Energy announced one-for-fifty reverse stock split.
- Scopus BioPharma Inc. (NASDAQ: SCPS) fell 14.7% to $0.2895 in pre-market trading after climbing around 45% on Thursday.
- Cryptyde, Inc. (NASDAQ: TYDE) shares fell 11.9% to $0.2302 in pre-market trading.
- RenovoRx, Inc. (NASDAQ: RNXT) fell 11.1% to $2.00 in pre-market trading. RenovoRx announced acceptance of four clinical data abstracts at the 2023 ASCO Gastrointestinal Cancers (ASCO GI) Symposium.
- HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) fell 10.5% to $0.5690 in pre-market trading after declining 7% on Thursday.
- Bionano Genomics, Inc. (NASDAQ: BNGO) fell 10.4% to $1.73 in pre-market trading after dropping around 7% on Thursday.
- Ambrx Biopharma Inc. (NYSE: AMAM) fell 10.2% to $2.02 in pre-market trading after gaining 5% on Thursday.
- BeyondSpring Inc. (NASDAQ: BYSI) fell 9.2% to $1.39 in pre-market trading. BeyondSpring recently presented data with plinabulin for the prevention of docetaxel-induced neutropenia in patients with non-small cell lung cancer and breast cancer at three medical conferences.
- Arcos Dorados Holdings Inc. (NYSE: ARCO) fell 7.2% to $7.01 in pre-market trading. Arcos Dorados Holdings, last month, reported third-quarter FY22 sales growth of 27% year-on-year to $921.7 million, beating the consensus of $902.19 million.
- Novavax, Inc. (NASDAQ: NVAX) fell 4.6% to $10.80 in pre-market trading. Novavax said it has priced its underwritten public offering to sell 6.5 million shares of its common stock at $10 per share.